Error-Prone PCR (EP-PCR) Libraries
Random single-point mutations introduced across the entire gene length, with adjustable mutation rates (low to high) for incremental evolution.
Randomized Mutant Libraries are collections of gene variants generated by introducing random sequence changes, deletions, or insertions across a gene of interest. Unlike targeted mutagenesis, randomization explores a vast and unbiased sequence space, making it the most powerful strategy for Directed Evolution campaigns aimed at discovering novel or enhanced protein functions, such as improved enzyme activity, altered substrate specificity, or enhanced thermal stability, where the functional residues are unknown or difficult to predict.
CD Biosynsis offers sophisticated Randomized Mutant Libraries Service utilizing high-diversity techniques including Error-Prone PCR (EP-PCR) , DNA Shuffling, and specialized CRISPR-based methods. We provide tight control over the mutation rate and diversity (e.g., transitions vs. transversions) to ensure optimal library quality. Delivered as high-titer plasmid pools or ready-to-use phage display vectors, our randomized libraries guarantee the high coverage and complexity necessary to successfully screen millions of variants, leading directly to the discovery of superior biological properties.
Get a QuoteKey technical capabilities for robust Randomized Mutant Library construction:
Randomized libraries are essential for accelerating Directed Evolution and functional discovery:
De Novo Enzyme Engineering
Broadening substrate range, improving catalytic turnover (k_cat), or enhancing tolerance to industrial conditions (temperature, pH) for biocatalysis.
Improved Therapeutic Proteins
Enhancing the stability, solubility, or pharmacokinetics of antibodies, growth factors, or hormones for clinical applications.
Pathway Optimization & Titre Improvement
Randomizing key regulatory enzymes or transcription factors to find variants that increase the output of a biosynthetic pathway.
Vaccine & Antigen Development
Generating highly diverse variants of viral antigens to map immune escape routes or enhance immunogenicity.
We provide multiple randomization strategies to match your evolutionary goal:
Error-Prone PCR (EP-PCR) Libraries
Random single-point mutations introduced across the entire gene length, with adjustable mutation rates (low to high) for incremental evolution.
DNA Shuffling / Recombination Libraries
Fragmentation and reassembly of homologous genes (DNA shuffling) or parental variants to introduce powerful cross-over and functional recombination.
Customized Randomization Biases
Tailoring the PCR conditions (e.g., Mn^2+ concentration) to selectively favor G :C to A :T transitions or transversions, guiding the mutation spectrum.
High-Capacity Vector Delivery
Cloning into high-titer vectors suitable for downstream screening platforms, including bacterial expression, phage display, and yeast surface display.
Guaranteed Library Size
Commitment to achieving a validated transformation and plating capacity (e.g., 10^8 independent clones) necessary for robust library coverage.
Our robust workflow ensures high diversity and controlled mutation frequency for effective evolutionary campaigns:
We provide specialized assurance for all your Directed Evolution projects:
What is the optimal mutation rate for Error-Prone PCR?
The optimal rate is typically 1 to 3 amino acid changes per gene. This ensures a high frequency of functional variants while minimizing the chance of accumulating multiple deleterious mutations. We tune the PCR conditions to meet your target rate.
How large of a library can you guarantee?
For most applications, we can guarantee transformation efficiencies yielding 10^7 to 10^8 independent clones. For highly specific projects (e.g., DNA shuffling), please contact us for custom feasibility and capacity assessments.
How does DNA Shuffling differ from EP-PCR?
EP-PCR introduces random point mutations across one gene. DNA Shuffling combines beneficial mutations from two or more homologous parental genes by fragmentation and recombination, creating powerful chimeric variants that combine features from the parents.
What QC do you perform to verify the randomization?
We verify the size of the library (independent clones) by plating. Crucially, we sequence a random set of clones or perform deep NGS on the pool to confirm that the achieved mutation rate and distribution (G :C to A :T bias) aligns with the design specifications.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.